Stay updated on Clinical Trial of KB103 for DEB Patients
Sign up to get notified when there's something new on the Clinical Trial of KB103 for DEB Patients page.

Latest updates to the Clinical Trial of KB103 for DEB Patients page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdd: new government operating-status notice, a new resource entry for Epidermolysis bullosa dystrophica, and version to v3.2.0. Delete: version v3.1.0.SummaryDifference5%
- Check19 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removal of 'Back to Top' is a minor UI change.SummaryDifference0.3%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information related to Beremagene Geperpavec and various diseases. Notably, previous references to specific locations and certain diseases have been removed.SummaryDifference3%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial of KB103 for DEB Patients
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of KB103 for DEB Patients page.